| A Clinical Study of a Zoster Vaccine in Healthy Adults >= 40 Years (NCT04072497) | Shanghai Institute Of Biological Products | 2018-11-20 |
| To Evaluate the Efficacy and Safety of CAN008 Combined With Re-irradiation (rRT) for Treating Patients With Recurrent Glioblastoma (GBM) (NCT03746288) | CANbridge Life Sciences Ltd. | 2018-11-20 |
| A Study of Efficacy and Safety of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis (NCT03662542) | Janssen Research & Development, LLC | 2018-11-20 |
| A First-in-Human Study of JAB-3068 (SHP2 Inhibitor) in Adult Patients With Advanced Solid Tumors in China (NCT03565003) | Jacobio Pharmaceuticals Co., Ltd. | 2018-11-20 |
| Safety and Efficacy of Intra-Arterial and Intra-Tumoral Ad-p53 With Capecitabine (Xeloda) or Anti-PD-1 in Liver Metastases of Solid Tumors and Recurrent Head and Neck Squamous Cell Cancer (NCT02842125) | MultiVir, Inc. | 2018-11-20 |
| A Study of ASP8302 in Participants With Underactive Bladder (NCT03702777) | Astellas Pharma Europe B.V. | 2018-11-20 |
| Hypofractionated Radiation Therapy in Treating Participants With Breast Cancer Before Surgery (NCT03624478) | Mayo Clinic | 2018-11-20 |
| Radiation and Chemotherapy With Ipilimumab Followed by Nivolumab for Patients With Stage III Unresectable Non-Small Cell Lung Cancer (NSCLC) (NCT03663166) | H. Lee Moffitt Cancer Center and Research Institute | 2018-11-20 |
| A Study of BAY3427080 (NT-814) in the Treatment of Moderate to Severe Post-menopausal Vasomotor Symptoms (NCT03596762) | Bayer | 2018-11-20 |
| Topical Ruxolitinib for Cutaneous Chronic Graft Versus Host Disease (cGVHD) (NCT03395340) | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 2018-11-19 |
| Efficacy and Safety of MEDI7352 in Participants With Painful Diabetic Neuropathy (NCT03755934) | AstraZeneca | 2018-11-19 |
| Phase 1/2 Dose Finding and Safety Study of Ibrutinib in Pediatric Subjects With Chronic Graft Versus Host Disease (cGVHD) (NCT03790332) | Pharmacyclics LLC. | 2018-11-19 |
| IV or IV/PO Omadacycline vs. IV/PO Levofloxacin for the Treatment of Acute Pyelonephritis (NCT03757234) | Paratek Pharmaceuticals Inc | 2018-11-19 |
| Efficacy and Safety of TD-1473 in Crohn's Disease (NCT03635112) | Theravance Biopharma | 2018-11-19 |
| Carfilzomib, Lenalidomide and Dexamethasone Versus Lenalidomide and Dexamethasone in High- Risk SMM (NCT03673826) | Stichting Hemato-Oncologie voor Volwassenen Nederland | 2018-11-19 |
| Durvalumab Plus Tremelimumab With Concurrent Radiotherapy for Localized Muscle Invasive Bladder Cancer Treated With a Selective Bladder Preservation Approach (NCT03702179) | Spanish Oncology Genito-Urinary Group | 2018-11-19 |
| Effect of Nilotinib in Cerebellar Ataxia Patients (NCT03932669) | Seoul National University Hospital | 2018-11-19 |
| SYNergy Stent® System Implantation With Mandatory Intra-VascularUltra-Sound Guidance and Dual Anti-Platelet Therapy (NCT03606642) | HonorHealth Research Institute | 2018-11-19 |
| Phase 2 Trial of Mesenchymal Stem Cells in Systemic Lupus Erythematosus (MiSLE) (NCT02633163) | Medical University of South Carolina | 2018-11-18 |
| The Synapse Project (NCT04871074) | University of Wisconsin, Madison | 2018-11-18 |
| First Line Metastatic Pancreatic Cancer : 5FU/LV+Nal-IRI, Gemcitabine+Nab-paclitaxel or a Sequential Regimen of 2 Months 5FU/LV+Nal-IRI (NCT03693677) | Federation Francophone de Cancerologie Digestive | 2018-11-16 |
| A Phase 2 Study Adding Ascorbate to Chemotherapy and Radiation Therapy for NSCLC (NCT02905591) | Joseph J. Cullen, MD, FACS | 2018-11-16 |
| First-time-in-human (FTIH) Study of GSK3145095 Alone and in Combination With Other Anticancer Agents in Adults With Advanced Solid Tumors (NCT03681951) | GlaxoSmithKline | 2018-11-16 |
| Second-Line Chemotherapy With Ramucirumab +/- Paclitaxel in Elderly Advanced Gastric or Gastroesophageal Junction Cancer Patients (NCT03760822) | Federation Francophone de Cancerologie Digestive | 2018-11-16 |
| Durvalumab Plus Olaparib Administered Prior to Surgery of Resectable Urothelial Bladder Cancer (NEODURVARIB) (NCT03534492) | Spanish Oncology Genito-Urinary Group | 2018-11-16 |
| Phase II of Lenalidomide After Salvage Therapy in R/R Non-Hodgkin T-cell Lymphoma (NCT03730740) | Samsung Medical Center | 2018-11-16 |
| Adjuvant De-Escalated Radiation + Adjuvant Nivolumab for Intermediate-High Risk P16+ Oropharynx Cancer (NCT03715946) | Robert L. Ferris, MD, PhD | 2018-11-16 |
| Study of Nivolumab and Relatlimab in Advanced Mismatch Repair Deficient Cancers Resistant to Prior PD-(L)1 Inhibitor (NCT03607890) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2018-11-16 |
| A Study to Evaluate the Safety and Efficacy of BIIB104 in Participants With Cognitive Impairment Associated With Schizophrenia (CIAS) (NCT03745820) | Biogen | 2018-11-15 |
| Efficacy of Durvalumab in Non-muscle-invasive Bladder Cancer (NCT03759496) | Hellenic GenitoUrinary Cancer Group | 2018-11-15 |
| Study to Evaluate the Safety and Efficacy of TSR-042, Bevacizumab, and Niraparib in Participants With Recurrent Ovarian Cancer (NCT05751629) | Tesaro, Inc. | 2018-11-15 |
| Alleviation by Fisetin of Frailty, Inflammation, and Related Measures in Older Adults (NCT03675724) | Mayo Clinic | 2018-11-15 |
| The Effect of PC945 on Aspergillus or Candida Lung Infections in Patients With Asthma or Chronic Respiratory Diseases (NCT03745196) | Pulmocide Ltd | 2018-11-15 |
| Intravitreal Methotrexate and R2(Rituximab & Lenalidomide) Regimen in Newly-diagnosed Primary Vitreoretinal Lymphoma (NCT03746223) | Peking Union Medical College Hospital | 2018-11-15 |
| the Efficacy and Safety of Sugammadex in Children 0-2 Years Old (NCT03728543) | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2018-11-15 |
| Treatment of Metastatic Castrate Resistant Prostate Cancer Patients According to Circulating Tumor Cells Kinetic (NCT03101046) | UNICANCER | 2018-11-15 |
| Anlotinib Combined With Docetaxel for Advanced Non-Small Cell Lung Cancer（ALTER-L034） (NCT03735264) | The Affiliated Hospital of Qingdao University | 2018-11-15 |
| Intra Articular Injection of Microfat and PRP in Knee Osteoarthritis (NCT04352075) | Clinique Juge | 2018-11-15 |
| Salicylic Augmentation in Depression (NCT03152409) | Jessica Harder | 2018-11-15 |
| Technology Enhanced Family Treatment (NCT03913013) | University of California, Los Angeles | 2018-11-15 |
| A Study of LY3209590 in Participants With Type 2 Diabetes Mellitus (NCT03736785) | Eli Lilly and Company | 2018-11-15 |
| Microbiota or Placebo After Antimicrobial Therapy for Recurrent C. Difficile at Home (MATCH) (NCT03005379) | VA Office of Research and Development | 2018-11-15 |
| Omnitram Safety and Efficacy in the Treatment of Diabetic Neuropathy (NCT03664921) | Syntrix Biosystems, Inc. | 2018-11-15 |
| Surgicel and Analgesic Reservoir (NCT03730714) | Assiut University | 2018-11-15 |
| Perioperative Analgesic Efficiency of Quadratus Lumborum Block vs Epidural in Radical Cystectomy (NCT04133051) | National Cancer Institute, Egypt | 2018-11-15 |
| Intrauterine Misoprostol Versus Rectal Misoprostol in Reducing Blood Loss During Cesarean Section (NCT03723031) | Cairo University | 2018-11-15 |
| Evaluation of Chitosan Scaffold and Mineral Trioxide Aggregate Pulpotomy in Mature Permanent Molars With Irreversible Pulpitis (NCT04308863) | Nourhan M.Aly | 2018-11-15 |
| Contezolid Acefosamil Versus Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infection (NCT03747497) | MicuRx | 2018-11-15 |
| A Study to Evaluate the Efficacy and Safety of Novel Treatment Combinations in Participants With Ovarian Cancer (NCT03574779) | Tesaro, Inc. | 2018-11-15 |
| Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients (NCT03449238) | Weill Medical College of Cornell University | 2018-11-15 |
| Carboplatin Plus Pemetrexed Plus Atezolizumab Plus Bevacizumab in Chemotherapy and Immunotherapy-naïve Patients With Stage IV Non-squamous Non-small Cell Lung Cancer (NCT03713944) | Nasser Hanna | 2018-11-15 |
| Pembrolizumab and Pelareorep in Treating Patients With Advanced Pancreatic Cancer (NCT03723915) | Northwestern University | 2018-11-14 |
| DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine INO-3112 and Durvalumab in Treating Patients With Recurrent or Metastatic Human Papillomavirus Associated Cancers (NCT03439085) | M.D. Anderson Cancer Center | 2018-11-14 |
| Ulixertinib in Treating Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial) (NCT03698994) | National Cancer Institute (NCI) | 2018-11-14 |
| Study of VIR-2218 in Healthy Subjects and Patients With Chronic Hepatitis B (NCT03672188) | Vir Biotechnology, Inc. | 2018-11-14 |
| A Study to Assess the Safety and Efficacy of ZPL389 in Patients With Moderate to Severe Atopic Dermatitis (NCT03517566) | Novartis Pharmaceuticals | 2018-11-14 |
| CT-Guided Adaptive Radiation Therapy Combine With Anti-PD-1 Antibody Adjuvant Immunotherapy for Thoracic Cancer Patients (NCT03732430) | Taizhou Hospital | 2018-11-14 |
| Trial of Nicotinamide Riboside and Co-enzyme Q10 in Chronic Kidney Disease (NCT03579693) | University of Washington | 2018-11-14 |
| An Extension Study of AK002 in Patients With Eosinophilic Gastritis and/or Eosinophilic Duodenitis (NCT03664960) | Allakos Inc. | 2018-11-14 |
| Hemodynamic Evaluation of Levosimendan in Patients With PH-HFpEF (NCT03541603) | Tenax Therapeutics, Inc. | 2018-11-14 |
| Efficacy and Safety Trial of Rimegepant for Migraine Prevention in Adults (NCT03732638) | Pfizer | 2018-11-14 |
| SBRT +/- Pembrolizumab in Patients With Local-Regionally Recurrent or Second Primary Head and Neck Carcinoma (NCT03546582) | RTOG Foundation, Inc. | 2018-11-14 |
| ONC201 With a Methionine-Restricted Diet in Patients With Metastatic Triple Negative Breast Cancer (NCT03733119) | University of Wisconsin, Madison | 2018-11-13 |
| Study of Surzebiclimab (BGB-A425) and Alcestobart (LBL-007) in Combination With Tislelizumab in Advanced Solid Tumors (NCT03744468) | BeiGene | 2018-11-13 |
| Pembrolizumab in Preventing Lung Cancer in Patients With Stage I-II Non-Small Cell Lung Cancer or High-Risk Pulmonary Nodules, the IMPRINT-Lung Study (NCT03634241) | M.D. Anderson Cancer Center | 2018-11-13 |
| Radiolabeled Gallium-68 (68Ga-PSMA) for PET/CT Imaging to Detect Prostate Cancer (NCT03689582) | University of Michigan Rogel Cancer Center | 2018-11-13 |
| Gene Therapy for Children With CLN3 Batten Disease (NCT03770572) | Neela Therapeutics | 2018-11-13 |
| Trial of Cytisine in Adult Smokers (NCT03709823) | Achieve Life Sciences | 2018-11-13 |
| Vaccination With 6MHP, With or Without Systemic CDX-1127, in Patients With Stage II-IV Melanoma (NCT03617328) | Craig L Slingluff, Jr | 2018-11-13 |
| Neoadjuvant Endocrine Therapy, Palbociclib, Avelumab in Estrogen Receptor Positive Breast Cancer (NCT03573648) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2018-11-13 |
| Efficacy, Safety, and Pharmacokinetic Profiles of REGN3500 Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis (NCT03738423) | Regeneron Pharmaceuticals | 2018-11-13 |
| Botulinum Toxin A Injectable Solution in the Management of Bruxism: A Clinical Trial Study (NCT03827122) | Riyadh Colleges of Dentistry and Pharmacy | 2018-11-13 |
| Safety and Efficacy of Abatacept in IgG4-Related Disease (NCT03669861) | Massachusetts General Hospital | 2018-11-13 |
| Second-line Therapy for Patients With Progressive Poorly Differentiated Extra-pulmonary Neuroendocrine Carcinoma (NCT03837977) | The Christie NHS Foundation Trust | 2018-11-13 |
| Alpha/Beta TCD HCT in Patients With Inherited BMF Disorders (NCT03579875) | Masonic Cancer Center, University of Minnesota | 2018-11-13 |
| Expanded Natural Killer Cells Following Haploidentical HSCT for AML/MDS (NCT03300492) | University Hospital, Basel, Switzerland | 2018-11-12 |
| Nivolumab With Radiation Therapy and Bevacizumab for Recurrent MGMT Methylated Glioblastoma (NCT03743662) | Memorial Sloan Kettering Cancer Center | 2018-11-12 |
| OlaReDo - Olaratumab and Rechallenge With Doxorubicin in Soft Tissue Sarcoma Patients (NCT03698227) | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | 2018-11-12 |
| Trial of Tremelimumab in Patients With Previously Treated Metastatic Urothelial Cancer (NCT03557918) | Matthew Galsky | 2018-11-12 |
| Dupilumab in Chronic Spontaneous Urticaria (NCT03749135) | Charite University, Berlin, Germany | 2018-11-12 |
| IANB Success Rate With and Without Panoramic Help (NCT03786211) | Hormozgan University of Medical Sciences | 2018-11-12 |
| Efficacy and Safety of Intravitreal Conbercept With Modified Treat-and-Extend Regimens in Exudative AMD (NCT05539235) | First Affiliated Hospital of Chongqing Medical University | 2018-11-12 |
| Efficacy and Safety of Tisagenlecleucel in Adult Patients With Refractory or Relapsed Follicular Lymphoma (NCT03568461) | Novartis Pharmaceuticals | 2018-11-12 |
| Bendamustine/Rituximab Followed by Venetoclax and Rituximab for Treatment of Chronic Lymphocytic Leukemia (NCT03609593) | Nicole Lamanna | 2018-11-12 |
| Ultrasound-enhanced Delivery of Chemotherapy to Patients With Liver Metastasis From Breast- and Colorectal Cancer (NCT03477019) | St. Olavs Hospital | 2018-11-12 |
| A Study to Assess the Safety of GRF6021 Infusions in Subjects With Parkinson's Disease and Cognitive Impairment (NCT03713957) | Alkahest, Inc. | 2018-11-12 |
| Efficacy and Safety of REGN3500 Monotherapy and Combination of REGN3500 Plus Dupilumab in Adult Patients With Moderate-to-Severe Atopic Dermatitis (NCT03736967) | Regeneron Pharmaceuticals | 2018-11-12 |
| Study of the Safety, Pharmacodynamics, Efficacy, and PK of TIMP-GLIA in Subjects With Celiac Disease (NCT03738475) | Takeda | 2018-11-11 |
| A Study of An Adjuvanted Inactivated H7N9 Influenza Vaccine (NCT03755427) | Shanghai Institute Of Biological Products | 2018-11-10 |
| Study of Pembrolizumab in Patients With Early-Stage NK/T-cell Lymphoma, Nasal Type (NCT03728972) | Memorial Sloan Kettering Cancer Center | 2018-11-09 |
| Open Label Extension to Assess the Long-Term Safety and Tolerability of ZYN002 in Children and Adolescents With FXS (NCT03802799) | Zynerba Pharmaceuticals, Inc. | 2018-11-09 |
| Durvalumab + Tremelimumab ± Paclitaxel in Advanced BTC After Platinum Chemotherapy. (NCT03704480) | GERCOR - Multidisciplinary Oncology Cooperative Group | 2018-11-09 |
| Randomized Study Evaluating the Efficacy of Low Intensity Transcranial Electrical Stimulation (Tdcs) for the Relief of Dyspnea (NCT03640455) | Assistance Publique - Hôpitaux de Paris | 2018-11-09 |
| Durvalumab and "Booster" Radiation in Metastatic Adenocarcinoma of the Pancreas (NCT03490760) | Baptist Health South Florida | 2018-11-09 |
| Linear Energy Transfer (LET)-Optimized Intensity Modulated Proton Therapy (IMPT) as a Component of Definitive Chemoradiation for Newly Diagnosed Squamous Cell Carcinoma of the Anal Canal: a Feasibility Trial (NCT03690921) | M.D. Anderson Cancer Center | 2018-11-08 |
| BrUOG 355: Nivolumab to Tailored Radiation Therapy With Concomitant Cisplatin in the Treatment of Patients With Cervical Cancer (NCT03527264) | Brown University | 2018-11-08 |
| Rituximab Plus MG4101 Indolent CD20-positive Non-Hodgkin Lymphoma (NHL) (NCT03578198) | Seoul National University Hospital | 2018-11-08 |
| Efficacy and Safety of Chinese Medicine JCM-16021 for Diarrhea-predominant Irritable Bowel Syndrome (NCT03457324) | ZhaoXiang Bian | 2018-11-08 |
| Zelquistinel in the Treatment of Adults With Major Depressive Disorder (NCT03726658) | Syndeio Biosciences, Inc | 2018-11-08 |
| Safety and Effectiveness of Propagermanium in Focal Segmental Glomerulosclerosis Participants Receiving Irbesartan (NCT03649152) | Dimerix Bioscience Pty Ltd | 2018-11-08 |